Nuclear factor-κB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats

Brain Research

Volumn 1081, Issue 1, 2006, Pages 211-218

  Wang, Jiantao ^a   Jiang, Shaoyun ^b   Kwong, Jacky M K ^c   Sanchez, Ruben N ^a   Sadun, Alfredo A ^a   Lam, Tim T ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

Author keywords

IL 6; Ischemia Reperfusion; Microglial phagocytic cell; NF B p65; siRNA

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CELL MARKER; HELENALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; SMALL INTERFERING RNA; SYNAPTOTAGMIN; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; LEUPEPTIN; NONSTEROID ANTIINFLAMMATORY AGENT; SESQUITERPENE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; MICROGLIA; NERVE CELL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RETINA; RETINA ISCHEMIA; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; CELL COUNT; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LEWIS RAT; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA GANGLION CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANIMALIA;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL COUNT; CYSTEINE PROTEINASE INHIBITORS; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LEUPEPTINS; MALE; NF-KAPPA B; RATS; RATS, INBRED LEW; REPERFUSION INJURY; RETINA; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SESQUITERPENES; TIME FACTORS;

EID: 33645856471     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.01.077     Document Type: Article

References (51)

1. Akira A., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., and Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9 (1990) 1897-1906
2. Arai-Gaun S., Katai N., Kikuchi T., Kurokawa T., Ohta K., and Yoshimura N. Heme oxygenase-1 induced in Müller cells plays a protective role in retinal ischemia-reperfusion injury in rats. Invest. Ophthalmol. Visual Sci. 45 (2004) 4226-4232
3. Baldwin Jr. A.S. The NF-κB and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
4. Block F., Peter M., and Nolden-Koch M. Expression of IL-6 in the ischemic penumbra. NeuroReport 11 (2000) 963-967
5. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P.A., and Neumeier D. Activated transcription factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97 (1996) 1715-1722
6. Chen Y.G., Zhang C., Chiang S.K., Wu T., and Tso M.O. Increased nuclear factor-κB p65 immunoreactivity following retinal ischemia and reperfusion injury in mice. J. Neurosci. Res. 72 (2003) 125-131
7. Chiang S.K., and Lam T.T. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage. Invest. Ophthalmol. Visual Sci. 41 (2000) 3310-3314
8. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
9. Dendorfer U., Oettgen P., and Libermann T.A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP and lipopolysaccharide. Mol. Cell. Biol. 14 (1994) 4443-4454
10. Dihne M., and Block F. Focal ischemia induces transient expression of IL-6 in the substantia nigra pars reticulata. Brain Res. 889 (2001) 165-173
11. Dihne M., Peters M., and Block F. Interleukin-6 expression in exo-focal neurons after striatal cerebral ischemia. NeuroReport 12 (2001) 3143-3148
12. Domanska-Janik K., Bronisz-Kowalczyk A., Zajac H., and Zablocka B. Interrelation between nuclear-factor kappa B activation, glial response and neuronal apoptosis in gerbil hippocampus after ischemia. Acta Neurobiol. Exp. (Wars) 1 (2001) 45-51
13. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
14. Fiedler M.A., Wernke-Dollries K., and Stark J.M. Inhibition of TNF-α-induced NF-κB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am. J. Respir. Cell Mol. Biol. 19 (1998) 259-268
15. Gabriel C., Justicia C., Camins A., and Planas A.M. Activation of nuclear factor-κB in the rat brain after transient focal ischemia. Mol. Brain Res. 65 (1999) 61-69
16. Gadient R.A., and Otten U.H. Interleukin-6 (IL-6)-A molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52 (1997) 379-390
17. Garden G.A. Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40 (2002) 240-251
18. Gellrich M.M., and Gellrich N.C. Quantitative relations in the retinal ganglion cell layer of the rat: neurons, glia and capillaries before and after optic nerve section. Graefe Arch. Clin. Exp. Ophthalmol. 234 (1996) 315-323
19. Gruol D.L., and Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15 (1997) 307-339
20. Harborth J., Elbashir S.M., Bechert K., Tuschl T., and Weber K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114 (2001) 4557-4565
21. Hu X., Nesic-Taylor O., Qiu J., Rea H.C., Fabian R., Rassin D.K., and Perez-Polo J.R. Activation of nuclear factor-κB signaling pathway by interleukin-1 after hypoxia/ischemia in neonatal rat hippocampus and cortex. J. Neurochem. 93 (2005) 26-37
22. Inden M., Kondo J., Kitamura Y., Takata K., Nishimura K., Taniguchi T., Sawada H., and Shimohama S. Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats. J. Pharmacol. Sci. 97 (2005) 203-211
23. Inomata Y., Hirata A., Yonemura N., Koga T., Kido N., and Tanihara H. Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage. Biochem. Biophys. Res. Commun. 302 (2003) 226-232
24. Kaltschmidt C., Kaltschmidt B., Lannes-Vieira J., Kreutzberg G.W., Wekerle H., Baeuerle P.A., and Gehrmann J. Transcription factor NF-kappaB is activated in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55 (1994) 99-106
25. Laderach D., Compagno D., Danos O., Vainchenker W., and Galy A. RNA interference shows critical requirement for NF-κB p50 in the production of IL-12 by human dendritic cells. J. Immunol. 171 (2003) 1750-1757
26. Libermann T.A., and Baltimore D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10 (1990) 2327-2334
27. Lingor P., Koeberle P., Kügler S., and Bahr M. Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo. Brain 128 (2005) 550-558
28. Loddick S.A., Turnbull A.V., and Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18 (1998) 176-179
29. Lyss G., Schmidt T.J., Merfort I., and Pahl H.L. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB. Biol. Chem. 378 (1997) 951-961
30. Lyss G., Knorre A., Schmidt T.J., Pahl H.L., and Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65. J. Biol. Chem. 273 (1998) 33508-33516
31. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsuskima K., Kishimoto T., and Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10193-10197
32. Mendonca Torres P.M., and de Araujo E.G. Interleukin-6 increases the survival of retinal ganglion cells in vitro. J. Neuroimmunol. 117 (2001) 43-50
33. Peng Y.P., Qiu Y.H., Lu J.H., and Wang J.J. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci. Lett. 374 (2005) 192-196
34. Reich S.J., Fosnot J., Kuroki A., Tang W., Yang X., Maguire A.M., Bennett J., and Tolentino M.J. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vision 9 (2003) 210-216
35. Romeo G., Liu W.H., Asnaghi V., Kern T.S., and Lorenzi M. Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51 (2002) 2241-2248
36. Sanchez R.N., Chan C.K., Garg S., Kwong J.M., Wong M.J., Sadun A.A., and Lam T.T. Interleukin-6 in retinal ischemia reperfusion injury in rat. Invest. Ophthalmol. Visual Sci. 44 (2003) 4006-4011
37. Schiefer J., Topper R., Schmidt W., Block F., Heinrich P.C., Noth J., and Schwarz M. Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid. J. Neuroimmunol. 89 (1998) 168-176
38. Sehagal P.B. Regulation of IL6 gene expression. Res. Immunol. 143 (1992) 724-734
39. Senaldi G., Varnum B.C., Sarmiento U., Starnes C., Lile J., Scully S., Guo J., Elliott G., McNinch J., Shaklee C.L., Freeman D., Manu F., Simonet W.S., Boone T., and Chang M.S. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11458-11463
40. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
41. Suzuki S., Tanaka K., Nagata E., Ito D., Dembo T., and Fukuuchi Y. Cerebral neurons expression interleukin-6 after transient forebrain ischemia in gerbils. Neurosci. Lett. 262 (1999) 117-120
42. 2+ channels after cerebral ischemia. NeuroReport 11 (2000) 2565-2569
43. Taga T., and Kishimoto T.E. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15 (1997) 797-819
44. Tanabe O., Akira S., Kamiya T., Wong G.G., Hirano T., and Kishimoto T. Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. J. Immunol. 141 (1988) 3875-3881
45. Takahashi K., Lam T.T., Edward D.P., Buchi E.R., and Tso M.O. Protective effects of flunarizine on ischemic injury in the rat retina. Arch. Ophthalmol. 110 (1992) 862-870
46. Vanden Berghe W., De Bosscher K., Boone E., Plaisance S., and Haegeman G. The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcription activation of the interleukin-6 gene promoter. J. Biol. Chem. 274 (1999) 32091-32098
47. Van Wagoner N.J., and Benveniste E.N. Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100 (1999) 124-139
48. Zhang Y.H., Lin J.X., and Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a κB-like sequence. Mol. Cell Biol. 10 (1990) 3818-3823
49. Zhang C., Takahashi K., Lam T.T., and Tso M.O. Effects of basic fibroblast growth factor in retinal ischemia. Invest. Ophthalmol. Visual Sci. 35 (1994) 3163-3168
50. Zhang W., Potrovita I., Tarabin V., Herrmann O., Beer V., Weih F., Schneider A., and Schwaninger M. Neuronal activation of NF-κB contributes to cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 25 (2005) 30-40
51. Zheng Z., and Yenari M.A. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol. Res. 26 (2004) 884-892